NJ State Employees Deferred Compensation Plan’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-175	Closed	-$54K	–	489
2017 Q4	$54K	Hold	175	–	–	0.01%	460
2017 Q3	$64K	Hold	175	–	–	0.01%	453
2017 Q2	$64K	Hold	175	–	–	0.01%	406
2017 Q1	$52K	Hold	175	–	–	0.01%	385
2016 Q4	$39K	Hold	175	–	–	0.01%	365
2016 Q3	$42K	Hold	175	–	–	0.01%	365
2016 Q2	$34K	Buy	+175	New	+$80.7K	0.01%	371

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's DMK Position: Q1 2018 in Review

NJ State Employees Deferred Compensation Plan sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2018, closing a stake of 175 shares — an estimated $54K sold.

NJ State Employees Deferred Compensation Plan first reported a position in DMK in Q2 2016 and held it in 7 quarters. The position peaked at $64K in Q3 2017. 52 funds tracked by Wall St. Rank hold DMK as of Q1 2018.

NJ State Employees Deferred Compensation Plan reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2018 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 175 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2018, an estimated $54K.
NJ State Employees Deferred Compensation Plan first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2016 and held it in 7 quarters.
NJ State Employees Deferred Compensation Plan's DMK Pharmaceuticals Corporation Common Stock position peaked at $64K in Q3 2017.
52 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2018.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2018, filed 2 May 2018.